Printer Friendly
The Free Library
14,635,542 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

SS Pharmaceutical to Market New Version of Its OTC Vitamin B Preparation Lolan BB.


Tokyo, Japan, July 26, 2005 - (JCNN JCNN Japan Corporate News Network ) - SS Pharmaceutical announced on July 25 that it has improved its over-the-counter (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
) vitamin B preparation, Lolan BB, and will put it on sale on August 10.

Lolan BB contains vitamin B2, B6, C, vitamin B1 derivative, and biotin biotin: see vitamin; coenzyme.
biotin

Organic compound, part of the vitamin B complex, essential for growth and well-being in animals and some microorganisms.
, and is helpful for women who have skin problems.

A 60-tablet bottle retails for 1,344 yen ($12), a 120-tablet bottle for 2,499 yen ($22), a 180-tablet bottle for 3,549 yen ($32) and a 250-tablet for 4,704 yen ($42).

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jul 26, 2005
Words:103
Previous Article:Mitsubishi Motors to Achieve Low Indoor VOC Concentrations for Its New Mini Vehicle to Be Released Next Spring.
Next Article:Takara Bio Releases High-fidelity PCR Enzyme PrimeSTAR HS DNA Polymerase.



Related Articles
American Diversified Group Inc. announces shipment of products to Guinea.
BioProgress Technology Launches New Website.
BioProgress Enters Agreement to Begin System Development Utilizing Its Unique XGel Technology.
BioProgress Executes License Arrangement for a Variation of XGel Technology.
BioProgress Executes New Development Agreement with Global Pharmaceutical Company.
Over a Five Year Period OTC Healthcare in UK Grew by 4.5% Per Year.
OTC Pharmaceuticals Market is Forecast to Accelerate Current Performance.(Industry overview)
Leiner Health Products Announces the Introduction of Famotidine 20 mg Tablets (Compare to the Active Ingredient in Maximum Strength Pepcid(R)* AC).
The Market for OTC Healthcare in Taiwan Increased Between 2000-2005, Growing at an Average Annual Rate of 5.3%.
Spot Future Trends And Developments Of The OTC Pharmaceuticals Markets In Singapore.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles